← Open Payments lookup

MING CHAO: Open Payments

NPI 1285821355 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$485 in 6 payments from 6 companies in 2025. Trend: 2023 $780 · 2024 $1,025 · 2025 $485

Food & beverage: $485
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.1$133
Neurocrine BioSciences, Inc.1$126
ACADIA Pharmaceuticals Inc1$118
Lundbeck LLC1$60
Gilead Sciences, Inc.1$24
Smith+Nephew, Inc.1$24

Products named: NUPLAZID, REXULTI, Livdelzi, STRAVIX PL.

Industry payments across TX — which companies pay providers there.